6QE-17296-19915
4 vaccinations
3 coded responses
24 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 973 / OR
- Registered
- 2021-02-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-02-08
Registered in v-safe
- 2021-02-08
- 2021-02-09
-
2021-02-10
Dose 2 — Pfizer-BioNTech
-
2021-02-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Vomiting, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-25
- 2021-03-03
- 2021-03-12
- 2021-03-17
- 2021-03-24
- 2021-05-12
-
2021-08-11
Survey response — 6 months, dose 2MedDRA: Chest discomfort, Chest pain, Cough, Exposure to chemical pollution, Impaired work ability, Office visit, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Asthma from concrete dust exposure (7/26). Symptoms include coughing, chest pain, chest tightness. Required medical visit(8/1) for treatment. Severe symptoms on (8/6) causing me to be unable to work. Current chronic chest pain and occasional cough.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-11
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-19
-
2021-11-05
Dose 3 — Pfizer-BioNTech
-
2022-05-06
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Malaise, Oropharyngeal pain, Productive cough, SARS-CoV-2 test negative, Secretion discharge, Upper respiratory tract congestion, Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, sore throat, mucus, upper respiratory congestion, malaise, tiredness of 4 wks duration 4/5-5/5; phlem 2 wks during active infection. Medical provider diagnosed upper respiratory viral infection. 4 negative rapid COVID tests on different days.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-09
- 2022-05-09
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-10-10
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-12-17
-
2023-03-18
Survey response — 6 months, dose 4MedDRA: Chills, Malaise, Myalgia, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Asthma from concrete dust exposure (7/26). Symptoms include coughing, chest pain, chest tightness. Required medical visit(8/1) for treatment. Severe symptoms on (8/6) causing me to be unable to work. Current chronic chest pain and occasional cough. cut off by CDC
Release 11 — 6 months, dose 3
Symptoms: Cough, sore throat, mucus, upper respiratory congestion, malaise, tiredness of 4 wks duration 4/5-5/5; phlem 2 wks during active infection. Medical provider diagnosed upper respiratory viral infection. 4 negative rapid COVID tests on different days. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | ✓ | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Exposure to chemical pollution | ✓ | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Impaired work ability | ✓ | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Office visit | ✓ | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Upper respiratory tract congestion | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release